Asosingh K
Laboratorium voor Hematologie en Immunologie Faculteit Geneeskunde, VUB Laarbeeklaan 103-B 1090 Brussel.
Verh K Acad Geneeskd Belg. 2003;65(2):127-34.
Multiple myeloma (MM) is a deadly malignancy of plasma cells, localized in the bone marrow (BM), a microenvironment which supports their survival and growth. The malignant cells secrete high levels of immunoglobulins (serum paraprotein) and induce activation of osteoclasts, which results in osteolytic bone disease. The MM cells may have a medullar or an extramedullar origin. The fact that the disease is spread over the whole BM at the time of diagnosis implies a (re)circulation of the MM cells in the peripheral blood and a (re)entrance into the BM. The mechanisms by which the MM cells migrate (home) from the intravascular into the extravascular compartment of the BM are not known. It is also not known which subset(s) of the MM cell population initially enter(s) the BM and induce(s) myeloma. We addressed these questions in the 5TMM experimental mouse model of myeloma. The characteristics of this model are very similar to the human disease. According to the model of Butcher and Picker the homing of MM cells to the BM is assumed a multistep process, in which chemoattractants and adhesion molecules play a central role. We previously reported that 5TMM (5T2MM and 5T33MM) cells selectively home to the BM. However which chemoattractants and adhesion molecules are involved is not known. We provide experimental evidence that 5TMM cells are attracted by BM fibroblasts and that IGF-I is one of the BM fibroblast-derived chemoattractants for the MM cells. We demonstrate that direct contact between 5TMM cells and BM endothelium up-regulates the expression of chemoattractant receptors and adhesion molecules such as IGF-I receptor and CD44v6, which confer homing to the MM cells to the BM and enhance their adhesion to BM stroma. Our results furthermore show that CD44v10 is involved in the adhesive interactions between 5TMM cells and BM endothelial cells and that in vivo blocking of this interaction results in a reduced BM homing. Analysis of the in vivo homing and differentiation characteristics of immature (CD45+) and mature (CD45-) 5TMM cells revealed homing of both subsets to the BM. Both subpopulations were able to induce myeloma and, moreover, (de)differentiated into each other.
多发性骨髓瘤(MM)是一种致命的浆细胞恶性肿瘤,位于骨髓(BM)中,骨髓是支持其生存和生长的微环境。恶性细胞分泌高水平的免疫球蛋白(血清副蛋白)并诱导破骨细胞活化,从而导致溶骨性骨病。MM细胞可能起源于髓内或髓外。疾病在诊断时已扩散至整个骨髓这一事实意味着MM细胞在外周血中循环并再次进入骨髓。MM细胞从血管内迁移(归巢)至骨髓血管外腔室的机制尚不清楚。同样未知的是MM细胞群体中的哪些亚群最初进入骨髓并引发骨髓瘤。我们在骨髓瘤的5TMM实验小鼠模型中解决了这些问题。该模型的特征与人类疾病非常相似。根据Butcher和Picker的模型,MM细胞归巢至骨髓被认为是一个多步骤过程,其中趋化因子和黏附分子起着核心作用。我们之前报道过5TMM(5T2MM和5T33MM)细胞选择性归巢至骨髓。然而,具体涉及哪些趋化因子和黏附分子尚不清楚。我们提供实验证据表明5TMM细胞被骨髓成纤维细胞吸引,并且胰岛素样生长因子-I(IGF-I)是骨髓成纤维细胞衍生的吸引MM细胞的趋化因子之一。我们证明5TMM细胞与骨髓内皮细胞的直接接触会上调趋化因子受体和黏附分子如IGF-I受体和CD44v6的表达,这些分子赋予MM细胞归巢至骨髓的能力并增强它们与骨髓基质的黏附。我们的结果还表明CD44v10参与5TMM细胞与骨髓内皮细胞之间的黏附相互作用,并且在体内阻断这种相互作用会导致骨髓归巢减少。对未成熟(CD45 +)和成熟(CD45 -)5TMM细胞的体内归巢和分化特征分析显示这两个亚群均归巢至骨髓。这两个亚群都能够引发骨髓瘤,而且能够相互(去)分化。